153 related articles for article (PubMed ID: 28725226)
1. JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4
Zhou R; Chang Y; Liu J; Chen M; Wang H; Huang M; Liu S; Wang X; Zhao Q
Front Immunol; 2017; 8():781. PubMed ID: 28725226
[TBL] [Abstract][Full Text] [Related]
2. JNK pathway-associated phosphatase illustrates low expression and negative correlations with inflammation, disease activity, and T-helper 17 cells in inflammatory bowel disease children.
Wang C; Bai C; Mao C; Leng X; Wang F; Guo X
J Clin Lab Anal; 2022 Sep; 36(9):e24488. PubMed ID: 35908771
[TBL] [Abstract][Full Text] [Related]
3. JKAP relates to disease risk, severity, and Th1 and Th17 differentiation in Parkinson's disease.
Yang Q; Zhuang J; Cai P; Li L; Wang R; Chen Z
Ann Clin Transl Neurol; 2021 Sep; 8(9):1786-1795. PubMed ID: 34289265
[TBL] [Abstract][Full Text] [Related]
4. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
5. Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients.
Shi X; Yang W; Wang N; Zhu J
Medicine (Baltimore); 2019 Aug; 98(33):e16622. PubMed ID: 31415355
[TBL] [Abstract][Full Text] [Related]
6. The correlation between Jun N-terminal kinase pathway-associated phosphatase and Th1 cell or Th17 cell in sepsis and their potential roles in clinical sepsis management.
Yu D; Peng X; Li P
Ir J Med Sci; 2021 Aug; 190(3):1173-1181. PubMed ID: 33083958
[TBL] [Abstract][Full Text] [Related]
7. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
[TBL] [Abstract][Full Text] [Related]
8. JNK Pathway-Associated Phosphatase Deficiency Facilitates Atherosclerotic Progression by Inducing T-Helper 1 and 17 Polarization and Inflammation in an ERK- and NF-κB Pathway-Dependent Manner.
Chen X; Fang M; Hong J; Guo Y
J Atheroscler Thromb; 2024 May; ():. PubMed ID: 38797677
[TBL] [Abstract][Full Text] [Related]
9. JKAP, Th1 cells, and Th17 cells are dysregulated and inter-correlated, among them JKAP and Th17 cells relate to cognitive impairment progression in Alzheimer's disease patients.
Zeng J; Liu J; Qu Q; Zhao X; Zhang J
Ir J Med Sci; 2022 Aug; 191(4):1855-1861. PubMed ID: 34595688
[TBL] [Abstract][Full Text] [Related]
10. JNK pathway-associated phosphatase in acute ischemic stroke patients: Its correlation with T helper cells, clinical properties, and recurrence risk.
Zhao P; Huo H; Li J; Zhang W; Liu C; Jin B; Wang H; Wang C
J Clin Lab Anal; 2022 Aug; 36(8):e24535. PubMed ID: 35808912
[TBL] [Abstract][Full Text] [Related]
11. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.
Gao W; Gao L; Yang F; Li Z
J Clin Lab Anal; 2022 Jan; 36(1):e24153. PubMed ID: 34918391
[TBL] [Abstract][Full Text] [Related]
12. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
Wu W; He C; Liu C; Cao AT; Xue X; Evans-Marin HL; Sun M; Fang L; Yao S; Pinchuk IV; Powell DW; Liu Z; Cong Y
Gut; 2015 Nov; 64(11):1755-64. PubMed ID: 25281418
[TBL] [Abstract][Full Text] [Related]
13. IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.
Yang Y; Zhang C; Jing D; He H; Li X; Wang Y; Qin Y; Xiao X; Xiong H; Zhou G
Inflamm Bowel Dis; 2021 Feb; 27(3):407-417. PubMed ID: 32737976
[TBL] [Abstract][Full Text] [Related]
14. The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck.
Li JP; Yang CY; Chuang HC; Lan JL; Chen DY; Chen YM; Wang X; Chen AJ; Belmont JW; Tan TH
Nat Commun; 2014 Apr; 5():3618. PubMed ID: 24714587
[TBL] [Abstract][Full Text] [Related]
15. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
16. GPR65 promotes intestinal mucosal Th1 and Th17 cell differentiation and gut inflammation through downregulating NUAK2.
Lin R; Wu W; Chen H; Gao H; Wu X; Li G; He Q; Lu H; Sun M; Liu Z
Clin Transl Med; 2022 Mar; 12(3):e771. PubMed ID: 35343079
[TBL] [Abstract][Full Text] [Related]
17. JNK Pathway-Associated Phosphatase as a Serum Marker for Disease Activity and Treatment Outcome of Juvenile Idiopathic Arthritis.
Zhu S; Lv H; Luo Y; Huang Q; Shen J
Tohoku J Exp Med; 2021 Jan; 253(1):19-28. PubMed ID: 33441511
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
[TBL] [Abstract][Full Text] [Related]
19. JNK pathway-associated phosphatase associates with rheumatoid arthritis risk, disease activity, and its longitudinal elevation relates to etanercept treatment response.
Sun L; Tu J; Chen X; Dai M; Xia X; Liu C; Zhou Y
J Clin Lab Anal; 2021 Apr; 35(4):e23709. PubMed ID: 33547838
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of JKAP is correlated with elevated disease risk, advanced disease severity, higher inflammation, and poor survival in sepsis.
Zhao M; Huang X
J Clin Lab Anal; 2019 Sep; 33(7):e22945. PubMed ID: 31206807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
